HomeCompareONTTF vs FCPT

ONTTF vs FCPT: Dividend Comparison 2026

ONTTF yields 130.72% · FCPT yields 6.05%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ONTTF wins by $12.66M in total portfolio value
10 years
ONTTF
ONTTF
● Live price
130.72%
Share price
$1.53
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$12.71M
Annual income
$5,073,150.96
Full ONTTF calculator →
FCPT
FCPT
● Live price
6.05%
Share price
$23.65
Annual div
$1.43
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.1K
Annual income
$5,775.28
Full FCPT calculator →

Portfolio growth — ONTTF vs FCPT

📍 ONTTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodONTTFFCPT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ONTTF + FCPT cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ONTTF pays
FCPT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ONTTF
Annual income on $10K today (after 15% tax)
$11,111.11/yr
After 10yr DRIP, annual income (after tax)
$4,312,178.32/yr
FCPT
Annual income on $10K today (after 15% tax)
$514.49/yr
After 10yr DRIP, annual income (after tax)
$4,908.99/yr
At 15% tax rate, ONTTF beats the other by $4,307,269.33/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ONTTF + FCPT for your $10,000?

ONTTF: 50%FCPT: 50%
100% FCPT50/50100% ONTTF
Portfolio after 10yr
$6.38M
Annual income
$2,539,463.12/yr
Blended yield
39.81%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on FCPT right now

ONTTF
No analyst data
Altman Z
2.7
Piotroski
3/9
FCPT
Analyst Ratings
5
Buy
10
Hold
Consensus: Hold
Price Target
$27.00
+14.2% upside vs current
Range: $25.00 — $29.00
Altman Z
1.4
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ONTTF buys
0
FCPT buys
0
No recent congressional trades found for ONTTF or FCPT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricONTTFFCPT
Forward yield130.72%6.05%
Annual dividend / share$2.00$1.43
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8%
Portfolio after 10y$12.71M$49.1K
Annual income after 10y$5,073,150.96$5,775.28
Total dividends collected$11.64M$24.1K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: ONTTF vs FCPT ($10,000, DRIP)

YearONTTF PortfolioONTTF Income/yrFCPT PortfolioFCPT Income/yrGap
1← crossover$23,772$13,071.90$11,401$700.92+$12.4KONTTF
2$54,477$29,041.47$13,064$864.84+$41.4KONTTF
3$120,490$62,199.57$15,051$1,072.48+$105.4KONTTF
4$257,495$128,569.99$17,442$1,337.22+$240.1KONTTF
5$532,306$256,786.24$20,340$1,677.08+$512.0KONTTF
6$1,065,680$496,113.10$23,880$2,116.57+$1.04MONTTF
7$2,068,523$928,245.26$28,241$2,689.36+$2.04MONTTF
8$3,897,205$1,683,885.13$33,660$3,442.07+$3.86MONTTF
9$7,134,988$2,964,978.56$40,456$4,439.95+$7.09MONTTF
10$12,707,588$5,073,150.96$49,063$5,775.28+$12.66MONTTF

ONTTF vs FCPT: Complete Analysis 2026

ONTTFStock

Oxford Nanopore Technologies plc develops and commercializes a technology platform using nanopore-based sensing for the analysis of various types of molecules. The company offers MinION, a portable device for deoxyribonucleic acid and ribonucleic acid sequencing; GridION, a self-contained benchtop device for running and analyzing up to five MinION or Flongle flow cells; MinION Mk1C for basecalling and data analysis, touchscreen operation, and wireless connectivity; Flongle, an adapter for use in MinION or GridION devices to attach a Flongle flow cell; GridION Mk1, a benchtop nanopore sequencer; PromethION 2 Solo and PromethION 2, a low-cost access to high-yield PromethION sequencing; PromethION 24 and PromethION 48 benchtop nanopore-based sequencers for multiple users to deliver multi-sample and multi-experiment sequencing results; and VolTRAX, an USB-powered device, which automates laboratory processes upstream of nanopore sequencing. It also provides MinKNOW, a software that offers data acquisition, real-time analysis and feedback, local basecalling, and data streaming; Basecalling tools to determine the identity and order of bases on the DNA/RNA molecule; EPI2ME, a cloud-based data analysis platform for end-to-end analysis of nanopore data in real time; and EPI2ME Labs, a bioinformatics solution to assist users in developing their skills and confidence in the analysis of their nanopore-based sequencing data. In addition, the company is developing MinION Mk1D; Ubi; Plongle; and SmidgION products. It sells its products online. The company was formerly known as Oxford NanoLabs Limited and changed its name to Oxford Nanopore Technologies Limited in May 2008. Oxford Nanopore Technologies plc was incorporated in 2005 and is based in Oxford, the United Kingdom.

Full ONTTF Calculator →

FCPTREIT

FCPT, headquartered in Mill Valley, CA, is a real estate investment trust primarily engaged in the acquisition and leasing of restaurant properties. The Company seeks to grow its portfolio by acquiring additional real estate to lease, on a net basis, for use in the restaurant and retail industries.

Full FCPT Calculator →
📬

Get this ONTTF vs FCPT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ONTTF vs SCHDONTTF vs JEPIONTTF vs OONTTF vs KOONTTF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.